About PAM²L Biotechnologies
PAM²L Biotechnologies is a company based in China founded in 2021 by Zhong Chao.. PAM²L Biotechnologies has raised $14.81 million across 1 funding round from investors including Yunqi Partners, Xinwo Capital Holding Group and CoStone Capital. PAM²L Biotechnologies operates in a competitive market with competitors including AmerisourceBergen, Hybio Pharmaceutical, Dizal Pharma, Quanyuantang Pharmacy and Guiyang Xintian Pharmaceutical, among others.
- Headquarter China
- Founders Zhong Chao
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.81 M (USD)
in 1 rounds
-
Latest Funding Round
$14.81 M (USD), Seed
Jan 11, 2023
-
Investors
Yunqi Partners
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PAM²L Biotechnologies
PAM²L Biotechnologies has successfully raised a total of $14.81M through 1 strategic funding round. The most recent funding activity was a Seed round of $14.81 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $14.8M
-
First Round
First Round
(11 Jan 2023)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Seed - PAM²L Biotechnologies | Valuation | Yunqi Partners , Xinwo Capital Holding Group |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PAM²L Biotechnologies
PAM²L Biotechnologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Yunqi Partners, Xinwo Capital Holding Group and CoStone Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in tech startups by Yunqi Partners.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PAM²L Biotechnologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PAML Biotechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pam²l Biotechnologies Comparisons
Competitors of PAM²L Biotechnologies
PAM²L Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Hybio Pharmaceutical, Dizal Pharma, Quanyuantang Pharmacy and Guiyang Xintian Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical research and development are focused on oncology therapeutics.
|
|
| domain | founded_year | HQ Location |
Medical and pharmaceutical products are retailed offline and online.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical company in China
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products are sold via an e-commerce platform in China.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about PAM²L Biotechnologies
When was PAM²L Biotechnologies founded?
PAM²L Biotechnologies was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is PAM²L Biotechnologies located?
PAM²L Biotechnologies is headquartered in China.
Is PAM²L Biotechnologies a funded company?
PAM²L Biotechnologies is a funded company, having raised a total of $14.81M across 1 funding round to date. The company's 1st funding round was a Seed of $14.81M, raised on Jan 11, 2023.
What does PAM²L Biotechnologies do?
PAML Biotechnologies was founded in 2021 by Zhong Chao in China. Operations are centered on the bio-pharmaceutical sector, where products are supplied and wholesaled to various markets. Distribution activities are managed from the companys base in China, with a focus on wholesale services for pharmaceutical and biotechnological items. The domain pam2l.com supports online presence for these core functions.
Who are the top competitors of PAM²L Biotechnologies?
PAM²L Biotechnologies's top competitors include AmerisourceBergen, Hybio Pharmaceutical and Dizal Pharma.
Who are PAM²L Biotechnologies's investors?
PAM²L Biotechnologies has 5 investors. Key investors include Yunqi Partners, Xinwo Capital Holding Group, CoStone Capital, Yael Capital, and Fuhua Group.